Anti-abortion company Hobby Lobby reportedly invests retirement funds in abortion drugs
http://www.washingtonpost.com/news/morning-mix/wp/2014/04/02/anti-abortion-company-hobby-lobby-reportedly-invests-retirement-funds-in-abortion-drugs/?tid=hp_mm&hpid=z4
By Gail Sullivan
April 2 at 3:30 am
<snip>
Hobby Lobby is so committed to those principles that its gone to the U.S. Supreme Court to challenge a provision in the Affordable Care Act it says requires it to provide access to insurance that covers birth control for its employees, some forms of which it equates with abortion.
No wonder then, the glee emanating from some quarters Tuesday when
Mother Jones Molly Redden reported that the companys retirement plan holds $73 million in mutual funds with investments in companies that make abortion drugs.
Several of the mutual funds in Hobby Lobbys retirement plan have holdings in companies that manufacture the specific drugs and devices that the Green family, which owns Hobby Lobby, is fighting to keep out of Hobby Lobbys health care policies: the emergency contraceptive pills Plan B and Ella, and copper and hormonal intrauterine devices.
These companies include Teva Pharmaceutical Industries, which makes Plan B and ParaGard, a copper IUD, and Actavis, which makes a generic version of Plan B and distributes Ella. Other holdings in the mutual funds selected by Hobby Lobby include Pfizer, the maker of Cytotec and Prostin E2, which are used to induce abortions; Bayer, which manufactures the hormonal IUDs Skyla andMirena; AstraZeneca, which has an Indian subsidiary that manufactures Prostodin, Cerviprime, and Partocin, three drugs commonly used in abortions; and Forest Laboratories, which makes Cervidil, a drug used to induce abortions. Several funds in the Hobby Lobby retirement plan also invested in Aetna and Humana, two health insurance companies that cover surgical abortions, abortion drugs, and emergency contraception in many of the health care policies they sell.
The retirement plan comes with a generous company match, which amounted to $3.8 million in 2012.
<snip>